Skip to main content
. 2017 Aug 14;4(3):ofx167. doi: 10.1093/ofid/ofx167

Figure 1.

Figure 1.

(A) Survival by tuberculosis (TB) category at baseline assessment for antiretroviral therapy (ART)-naive human immunodeficiency virus (HIV)-infected participants. (B) Survival by TB category at baseline assessment for ART-naive HIV-infected participants with CD4 ≤100 cells/mm3. LAM, lipoarabinomannan.